NOX4 and cardiac hypertrophy: Moreover, aged (13–14 months) transgenic mice with cardiac-specific overexpression of NOX4 exhibited LV contractile dysfunction with increased myocardial fibrosis, apoptosis, oxidative stress and mitochondrial dysfunction, with no obvious cardiac hypertrophy [63].